Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Veeva Systems (GB:0LO3)
LSE:0LO3
Veeva Systems (0LO3) Share Forecast & Price Target
0 Followers
See the Price Targets and Ratings of:
0LO3 Analyst Ratings
Moderate Buy
13 Buy
7 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0LO3 Stock 12 Month Forecast
Average Price Target
$220.33
▲(14.31% Upside)
| Highest Price Target$260.00 | Average Price Target$220.33 | Lowest Price Target$173.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Analyst Performance
Any
Analyst Rating
Any
Upside / Downside
Any
Action
Any
Guggenheim
Reiterated
07/18/24
Morgan Stanley
Reiterated
07/17/24
Barclays
Assigned
07/16/24
Truist Financial
Assigned
07/16/24
Robert W. Baird
Reiterated
07/15/24
Oppenheimer
Reiterated
07/15/24
William Blair
Reiterated
07/15/24
Bank of America Securities
Reiterated
07/15/24
Piper Sandler
Assigned
07/12/24
RBC Capital
$250
Buy
$250.00
(29.70% Upside)
Reiterated
06/20/24
RBC Capital Remains a Buy on Veeva Systems (VEEV)
J.P. Morgan
$222→$203
Hold
$203.00
(5.32% Upside)
Reiterated
06/05/24
Analysts' Opinions Are Mixed on These Healthcare Stocks: Veeva Systems (NYSE: VEEV), Globus Medical (NYSE: GMED) and Alnylam Pharma (NASDAQ: ALNY)
UBS
$235→$185
Hold
$185.00
(-4.02% Downside)
Reiterated
05/31/24
Veeva price target lowered to $185 from $235 at UBSVeeva price target lowered to $185 from $235 at UBS
Evercore ISI
$230→$200
Hold
$200.00
(3.76% Upside)
Reiterated
05/31/24
Veeva price target lowered to $200 from $230 at Evercore ISIVeeva price target lowered to $200 from $230 at Evercore ISI
Canaccord Genuity
$220→$210
Hold
$210.00
(8.95% Upside)
Reiterated
05/31/24
Analysts Have Conflicting Sentiments on These Healthcare Companies: Ultragenyx Pharmaceutical (NASDAQ: RARE) and Veeva Systems (NYSE: VEEV)
Best Analysts Covering Veeva Systems
Which Analyst Should I Follow If I Want to Buy GB:0LO3 and Sell After:
1 Month
xxx
Success Rate
15/22 ratings generated profit
Average Return
+3.19%
assigned a xxx
rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 68.18% of your transactions generating a profit, with an average return of +3.19% per trade.
3 Months
xxx
Success Rate
14/22 ratings generated profit
Average Return
+2.46%
assigned a xxx
rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 63.64% of your transactions generating a profit, with an average return of +2.46% per trade.
1 Year
Success Rate
21/31 ratings generated profit
Average Return
+12.68%
reiterated a buy rating last month
Copying Rishi Jaluria's trades and holding each position for 1 Year would result in 67.74% of your transactions generating a profit, with an average return of +12.68% per trade.
2 Years
xxx
Success Rate
10/15 ratings generated profit
Average Return
+2.65%
reiterated a xxx
rating 13 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +2.65% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0LO3 Analyst Recommendation Trends
Rating
Mar 24
Apr 24
May 24
Jun 24
Jul 24
Strong Buy
0
0
0
0
0
Buy
22
28
36
27
22
Hold
7
9
12
11
10
Sell
2
2
3
1
2
Strong Sell
0
0
0
0
0
total
31
39
51
39
34
Each month's total comprises the sum of three months' worth of ratings.
0LO3 Financial Forecast
0LO3 Stock Forecast FAQ
What is GB:0LO3’s average 12-month price target, according to analysts?
Based on analyst ratings, Veeva Systems’s 12-month average price target is $220.33.
What is GB:0LO3’s upside potential, based on the analysts’ average price target?
Veeva Systems has 14.31% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Veeva Systems a Buy, Sell or Hold?
Veeva Systems has a consensus rating of Moderate Buy, which is based on 13 buy ratings, 7 hold ratings and 1 sell ratings.
What is Veeva Systems’s share price target?
The average share price target for Veeva Systems is $220.33. This is based on 21 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $260.00 ,and the lowest forecast is $173.00. The average share price target represents 14.31% Increase from the current price of $192.746.
The highest analyst share price target is $260.00 ,and the lowest forecast is $173.00. The average share price target represents 14.31% Increase from the current price of $192.746.
What do analysts say about Veeva Systems?
Veeva Systems’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 21 Wall Streets Analysts.
How can I buy shares of Veeva Systems?
To buy shares of GB:0LO3, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.